Per 
Special Containment Procedures:
SCP 6007 is to be stored in a locked medicine cabinet within Site 73, and all authorized personnel will possess a key to access the cabinet. Any unauthorized personnel trying to access SCP 6007 are to be warned once, then terminated if they continue.
Description:
SCP 6007 is the liquid stored in ten (10) medical syringes. Labelled as SCP 6007-1 through SCP 6007-10, these instances contain a viscous, translucent blue liquid. The total volume of liquid combined is roughly 25mL. SCP 6007-1 through SCP 6007-10 are stored in an ATA-Style briefcase designated as SCP 6007-A. SCP 6007-A appears to have previously stored ██ syringes.
SCP 6007-A, when opened, creates a cognitohazard that compels any form of licensed medical staff within a .5m radius-despite their level of training-to take and use an instance of SCP 6007-1 through 6007-10 on another human being. These individuals are now designated as SCP 6007-B, which will find one (1) individual to be their "patient". After administrating SCP 6007, instances of SCP 6007-B will return the syringe to SCP 6007-A. Instances of these "patients", known as SCP 6007-C upon injection, are seemingly chosen at random by instances of SCP 6007-B, but actual medical patients are prioritized if any are within a 2.5m radius of SCP 6007-B. Instances of SCP 6007-C are injected with a volume between 1.5mL to 3.5mL of liquid based on their BMI. The effects applied to instances of SCP 6007-B are nullified when SCP 6007-A is closed. The effect of the briefcase continues even after SCP 6007-B administers a dose of the liquid. Instances of SCP 6007-B refer to SCP 6007 as "The Blue Cure", and are unable to find any medicinal alternative to SCP 6007 despite its anomalous effects. Only Class-A amnestics seem to nullify this behavior.
After examination, the liquid is simply a saline solution with an additive containing blue dye, high fructose corn syrup, and an unknown substance that is most likely to give 6007instances its anomalous properties. Effects of the liquid are only present if it is injected into a human test subject by SCP 6007-B. Once injected, the liquid will take effect after three (3) minutes. Depending on the size of the dose, different effects occur within SCP 6007-C.
Unless approved by the site director, no more than 2.5mL of liquid are to be injected into a test subject (see Test Log 6007-A). After testing, five (5) syringes remain, with 2mL of liquid left in the fifth.
Addendum 6007-1: Recovery Report
SCP 6007 was discovered ██ miles outside of San Antonio, Texas in a small hospital. Dr. Cadenza, a recently hired Junior Researcher, was at this facility to receive his annual shot of ██████████; a preventative drug for various sicknesses and ailments. Soon after, he suffered mild convulsions for roughly twenty (20) minutes, along with nausea approximately ten (10) minutes. The physician who administered the shot stated that this new substance, named "The Blue Cure" by the hospital staff, was a better alternative, and was approved by the head of the facility. Roughly a week later, multiple patients had also been administered the shot were reporting effects similar to Dr. Cadenza. However, over ██% of patients died from ruptured blood vessels caused by SCP 6007. When interviewed, all physicians and doctors who administered the shot stated that patients didn't need anything else aside from "The Blue Cure". Those who survived had experienced similar symptoms as Dr. Cadenza. He contacted the Foundation in order to find the source, which was discovered in a storage room on the █th floor. At the time of discovery, briefcase was opened and missing ██ syringes. All doctors, physicians, patients, and others within the facility at the time of Dr. Cadanza's statement were given Class-A amnestics.
Test Logs:
Test A: Initial Testing - 01/19/20██
Subjects:
Six (6) instances of SCP 6007-B.
Three (3) D-Class, male, approximately 25-30 years of age.
Three (3) D-Class female, approximately 25-35 years of age.
Procedure:
Phase 1: One (1) D-Class male and female were injected with .5mL and 1mL, respectively, of SCP 6007. Subjects were placed in a standard humanoid containment cell.
Phase 2: One (1) D-Class male and female were injected with 1.5mL and 2.5mL, respectively, of SCP 6007. Subjects were placed in a standard humanoid containment cell.
Phase 3: One (1) D-Class male and female were injected with 3mL of SCP 6007. Subjects were placed in a standard humanoid containment cell.
Results:
Phase 1: No physical changes to their anatomy. Subjects report a feeling of nausea.
Phase 2: No physical changes to their anatomy. Subjects enter mild convulsions for approximately twenty (20) minutes, then revert to phase 1.
Phase 3: After three (3) minutes, the body violently convulses. Every blood vessel in the subject bursts, and death by bleeding out is imminent. The liquid recovered from the bodies has changed to a burnt orange color.
Analysis:
Instances of SCP 6007-C must be injected with no more that 2.5mL of liquid. Reason of bursting blood vessels is unclear.
